TYMS and hepatocellular carcinoma: The ratio of activity between oxyriboside transferring enzymes and deoxyriboside transferring enzyme is 3.5 and reduced to 0.06 in hepatoma [12], but 5-flurouracil forms complex with thymidylate synthase, preventing DNA components of ribonucleic acid (RNA) and DNA [50] in cancer patients.